News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
534,189 Results
Type
Article (33848)
Company Profile (177)
Press Release (500164)
Section
Business (155049)
Career Advice (798)
Deals (25270)
Drug Delivery (66)
Drug Development (59661)
Employer Resources (79)
FDA (14241)
Job Trends (11894)
News (259719)
Policy (24160)
Tag
Academia (2288)
Alliances (43379)
Alzheimer's disease (974)
Approvals (14240)
Artificial intelligence (172)
Bankruptcy (205)
Best Places to Work (9737)
Biotechnology (129)
Breast cancer (166)
Cancer (1240)
Cardiovascular disease (98)
Career advice (711)
CAR-T (94)
Cell therapy (261)
Clinical research (48332)
Collaboration (527)
Compensation (134)
COVID-19 (1976)
C-suite (123)
Data (1230)
Diabetes (147)
Diagnostics (5679)
Earnings (53910)
Events (75872)
Executive appointments (411)
FDA (14946)
Funding (427)
Gene therapy (164)
GLP-1 (454)
Government (3426)
Healthcare (15548)
Infectious disease (2054)
Interviews (99)
IPO (10875)
Job creations (2564)
Job search strategy (619)
Layoffs (232)
Legal (4943)
Lung cancer (188)
Manufacturing (159)
Medical device (13906)
Medtech (13911)
Mergers & acquisitions (14626)
Metabolic disorders (377)
Neuroscience (1236)
NextGen: Class of 2025 (5415)
Non-profit (3427)
Northern California (1360)
Obesity (203)
Opinion (118)
Patents (110)
People (47084)
Phase I (14947)
Phase II (21130)
Phase III (16304)
Pipeline (453)
Postmarket research (1810)
Preclinical (5821)
Radiopharmaceuticals (208)
Rare diseases (194)
Real estate (4616)
Regulatory (17058)
Research institute (2077)
Resumes & cover letters (114)
Southern California (1227)
Startups (3205)
United States (12904)
Vaccines (452)
Weight loss (139)
Date
Today (149)
Last 7 days (339)
Last 30 days (1551)
Last 365 days (27445)
2025 (1445)
2024 (27793)
2023 (31936)
2022 (42322)
2021 (45784)
2020 (44604)
2019 (39179)
2018 (29800)
2017 (26823)
2016 (25763)
2015 (30045)
2014 (22832)
2013 (19214)
2012 (20808)
2011 (21296)
2010 (19659)
Location
Africa (521)
Arizona (152)
Asia (33475)
Australia (5666)
California (3155)
Canada (1301)
China (317)
Colorado (153)
Connecticut (173)
Europe (70714)
Florida (496)
Georgia (130)
Illinois (344)
Indiana (201)
Japan (92)
Kansas (96)
Maryland (607)
Massachusetts (2272)
Michigan (189)
Minnesota (263)
New Jersey (975)
New York (925)
North Carolina (641)
Northern California (1360)
Ohio (133)
Pennsylvania (741)
South America (775)
Southern California (1227)
Texas (483)
Utah (107)
Washington State (348)
534,189 Results for "shine medical technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility
SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader in the development of innovative radiopharmaceuticals.
June 6, 2024
·
3 min read
Press Releases
GlyTherix to Partner with SHINE Technologies for Advancing Targeted Radiotherapy in Aggressive Cancers
September 18, 2024
·
4 min read
BioMidwest
SHINE Technologies to Exhibit at 7th Annual Theranostics World Congress
SHINE Technologies will showcase its innovative capabilities for producing non-carrier-added lutetium-177 (n.c.a Lu-177), a radioisotope used in targeted cancer treatments, at the 7th Theranostic World Congress (TWC), March 22-24 in Santiago, Chile.
March 18, 2024
·
2 min read
Policy
SHINE Technologies, LLC Announces Submission of FDA Drug Master File for Non-Carrier-Added Lutetium-177
SHINE Technologies, LLC, a pioneer in next-generation fusion-based technology, becomes North America’s largest producer of non-carrier added lutetium-177 chloride, a cutting-edge radiopharmaceutical used in precision cancer treatment, with a Drug Master File to the U.S. Food and Drug Administration.
April 8, 2024
·
3 min read
Press Releases
SHINE Technologies Collaborates with University of Wisconsin-Madison and WARF Therapeutics to Create Promising New Treatments for Kidney and Prostate Cancers
October 18, 2024
·
7 min read
Parkinson’s disease
A Month After Stunning Schizophrenia Fail, AbbVie’s Other Cerevel Asset Shines Again
Tavapadon improved motor and daily living complications at week 26. The news comes nearly one month to the day after AbbVie announced the Phase II failure of another key Cerevel asset, emraclidine.
December 9, 2024
·
1 min read
·
Annalee Armstrong
Business
SHINE Technologies and Nucleus RadioPharma Partner to Advance Radioligand Cancer Treatments
SHINE Technologies today announced a long-term supply agreement with Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals.
November 16, 2023
·
4 min read
Press Releases
Tsingke Shines at Cell & Gene Therapy International 2024
October 15, 2024
·
3 min read
News
SHINE Technologies Showcases FLARE™, the World’s Most Powerful Continuous Fusion Neutron System
July 22, 2024
·
3 min read
Press Releases
SHINE Technologies Awarded $32M by DOE/NNSA to Support Production of Molybdenum-99
July 17, 2024
·
3 min read
1 of 53,419
Next
